News Granules India Limited NSE India S.E.

Equities

GRANULES

INE101D01020

Delayed NSE India S.E. Other stock markets 11:50:55 2024-04-23 pm EDT			5-day change	1st Jan Change
415.4 ^INR	+0.22%		+0.22%	+2.49%

Apr. 15	Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	MT
Apr. 03	Granules India Unit Gets VAI Status for Virginia Facility	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	Apr. 15	MT
Granules India Unit Gets VAI Status for Virginia Facility	Apr. 03	MT
Granules India Limited Announces Appointment of Directors	Apr. 02	CI
Granules India Limited Announces Cessation of Arun Rao Akinepally as Independent Director	Mar. 29	CI
Granules India Limited Announces Appointment of Sethu Madhavan Sankaran as Senior Vice President - Api Manufacturing & Operations	Mar. 29	CI
Granules India Limited Appoints Atul Dhavle as Chief Human Resources Officer	Mar. 11	CI
Granules India Limited Announces That J. Shravan Reddy Shall Cease to Be Senior Vice President & Head- API Manufacturing	Mar. 05	CI
Transcript : Granules India Limited, Q3 2024 Earnings Call, Jan 23, 2024	Jan. 23
Paracetamol maker Granules India posts marginal rise in Q3 profit	Jan. 23	RE
Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit	Jan. 23	MT
Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 23	CI
Granules Pharmaceuticals Unit's Virginia Facility Gets Five Observations from US FDA	Dec. 18	MT
Granules India Gets US FDA Nod for Pantoprazole Sodium Delayed-Release Tablets	Dec. 13	MT
Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets	Dec. 13	CI
Granules India Arm Gets US FDA Nod for Sildenafil for Oral Suspension	Dec. 03	MT
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	Nov. 09	RE
Transcript : Granules India Limited, Q2 2024 Earnings Call, Nov 09, 2023	Nov. 09
Granules India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Granules India : Received ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules	23-10-19	PU
Granules India Gets US FDA's Approval for Generic Drug for GERD Symptoms	23-10-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Granules India Limited NSE India S.E.

Equities

GRANULES

INE101D01020

Summary

Filters